Results 211 to 220 of about 98,720 (282)

Commentary: Catalysts of violence against women students: the role of the university, aggressors, and victims. [PDF]

open access: yesFront Psychol
Díaz-Sosa DM   +4 more
europepmc   +1 more source

Examining the Mutual Gains Model of Well‐Being‐Oriented HRM: Evidence From the Healthcare Sector

open access: yesHuman Resource Management Journal, EarlyView.
ABSTRACT Well‐being‐oriented human resource management (WBHRM) posits the benefits for both employees and the employer. Yet, our review has revealed that sophisticated theorisation and subsequent empirical testing of such a mutual gains thesis are scarce. Against this backdrop, we attempt to do so in a highly demanding healthcare context.
Jongwook Pak   +1 more
wiley   +1 more source

Sleep regulation in <i>Drosophila</i>: a review of neural circuits and genetics. [PDF]

open access: yesFront Neurosci
Zhao Y   +7 more
europepmc   +1 more source

Responses to the pilot systematic review of problem-based learning. [PDF]

open access: yes
De Virgilio, Giovanni   +7 more
core   +1 more source

The correlation between sanction adjustments and drunk‐driving violations and related outcomes in Taiwan: A nationwide interrupted time series analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Drunk‐driving accounts for a significant portion of traffic crashes in Taiwan. From 2008 to 2013, both the Taiwan Legislative Yuan and the federal administrative agencies collaborated to increase drunk‐driving penalties.
Ling‐Wei Kuo   +9 more
wiley   +1 more source

When Is Resection of a Cardiac Tumor With Metastatic Disease Acceptable? [PDF]

open access: yesJACC Case Rep
Dhingra NK   +4 more
europepmc   +1 more source

Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a third‐generation, HER2‐targeting antibody‐drug conjugate that has been shown to significantly prolong overall survival, compared with standard chemotherapy, when used to treat patients who have “HER2‐low” (HER2 immunohistochemistry [IHC] score 1+; or HER2 IHC 2+ plus in situ hybridization‐negative ...
Andrew Redfern   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy